Culanag Jr, Francisco T.

HRN: 23-06-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2023
MEBENDAZOLE 500MG (TAB)
05/22/2023
05/22/2023
PO
500mg
SD
T/C Ascariasis
Waiting Final Action 
05/24/2023
CEFTRIAXONE 1G (VIAL)
05/24/2023
05/31/2023
IV
2g
Q24h
Complicated UTI
Waiting Final Action 
05/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/27/2023
06/03/2023
IV
1.5gms
Q6H
Septicemia Still With Febrile Episodes
Waiting Final Action 
08/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/11/2023
08/18/2023
IV
1.5gram
Q 6hrs
Acalculous Cholecystitis
Waiting Final Action 
08/12/2023
CEFTRIAXONE 1G (VIAL)
08/12/2023
08/18/2023
IV
2gm
Q24
Acalculous Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: